Kaken Pharmaceutical Co. Ltd Financials

Market Capitalization ¥150.33 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	10.37
Forward PE	39.32
Price to Sales TTM	¥1.60
Price to Book MRQ	¥0.95
Enterprise to Revenue	0.86
Enterprise to EBITDA	3.41

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2024-06-30
Profit Margin	14.83%
Operating Margin	-24.32%
Return on Assets TTM	7.26%
Return on Equity TTM	9.41%

Income Statement

Revenue TTM	¥94,035,001,344
Revenue per Share TTM	¥2464.10
Quarterly Revenue Growth	4.00%
Gross Profit TTM	¥58,532,999,168
EBITDA	¥23,893,000,000
Net Income to Common TTM	¥13,944,999,936
Diluted EPS TTM	¥365.55
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	¥70,085,001,216
Total Cash per Share MRQ	¥1824.95
Total Debt MRQ	¥
Total Debt to Equity MRQ	2.52
Current Ratio MRQ	3.67
Book Value per Share MRQ	¥3974.44

Cash Flow

Operating Cash Flow TTM	¥29,780,000,768
Levered Free Cash Flow TTM	¥22,979,999,744

4521 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	38,403,876
Float Shares	33,137,552
Avg 10 Volume	139,720
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	16.75%
% Held by Institutions	29.11%

Stock Price Summary

Beta	0.03
Fifty Two Week Low	¥3554.00
Fifty Two Week High	¥4901.00
Fifty Two Week Change	-4.06%
Day 50 MA	¥3850.76
Day 200 MA	¥4165.38

Dividends and Splits

Forward Annual Dividend Rate	¥150.00
Forward Annual Dividend Yield	3.96%
Trailing Annual Dividend Rate	¥115.00
Trailing Annual Dividend Yield	3.03%
Payout Ratio	41.05%
Dividend Date
Ex Dividend Date	2025-09-29
Last Split Factor
Last Split Date	2015-09-28